Design and Baseline Characteristics of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) Study

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 8,631 citations

The Effect of Pravastatin on Coronary Events after Myocardial Infarction in Patients with Average Cholesterol Levels

1996 • 7,450 citations

Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia

1995 • 7,378 citations

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trial

2002 • 6,780 citations

Primary Prevention of Acute Coronary Events With Lovastatin in Men and Women With Average Cholesterol Levels

1998 • 5,293 citations

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1998 • 5,229 citations

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1994 • 2,615 citations

Cerebral Vascular Accidents in Patients over the Age of 60: II. Prognosis

1957 • 2,312 citations

Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study.

1986 • 2,283 citations

Serum Cholesterol Levels and Six-Year Mortality from Stroke in 350,977 Men Screened for the Multiple Risk Factor Intervention Trial

1989 • 1,123 citations

Effect of lovastatin on early carotid atherosclerosis and cardiovascular events. Asymptomatic Carotid Artery Progression Study (ACAPS) Research Group.

1994 • 887 citations

Effect of Hydroxymethyl Glutaryl Coenzyme A Reductase Inhibitor Therapy on High Sensitive C-Reactive Protein Levels

2001 • 758 citations

Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)

1994 • 648 citations

Summary of the second report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 454 citations

Mevastatin, an HMG-CoA Reductase Inhibitor, Reduces Stroke Damage and Upregulates Endothelial Nitric Oxide Synthase in Mice

2001 • 328 citations

Reduction in Carotid Arterial Wall Thickness Using Lovastatin and Dietary Therapy

1996 • 326 citations

Stroke, Statins, and Cholesterol

1997 • 316 citations

Reduction in Stroke With Gemfibrozil in Men With Coronary Heart Disease and Low HDL Cholesterol

2001 • 265 citations

Low-density lipoprotein-independent effects of statins

1999 • 245 citations

Direct vascular effects of HMG-CoA reductase inhibitors

1998 • 225 citations

Reductase Inhibitor Monotherapy and Stroke Prevention

1997 • 213 citations

Anti-inflammatory effects of simvastatin in subjects with hypercholesterolemia

2001 • 179 citations

Direct Vascular Effects of HMG-CoA Reductase Inhibitors

2000 • 161 citations

Elevated serum cholesterol is a risk factor for both coronary heart disease and thromboembolic stroke in Hawaiian Japanese men. Implications of shared risk.

1994 • 132 citations

Cholesterol Reduction and Stroke Occurrence: An Overview of Randomized Clinical Trials

2000 • 101 citations

Hypercholesterolemia, lipid-lowering agents, and the risk for brain infarction

2001 • 83 citations

Assessing dietary adherence in the Multiple Risk Factor Intervention Trial (MRFIT). I. Use of a dietary monitoring tool.

1980 • 75 citations

Lipids and endothelial function: effects of lipid-lowering and other therapeutic interventions

1996 • 64 citations

Non—Lipid-lowering effects of statins on atherosclerosis

1999 • 61 citations

Direct Effects of Statins on Cells Primarily Involved in Atherosclerosis.

2000 • 39 citations

Reductase inhibitor monotherapy and stroke prevention

1997 • 36 citations

Deleted Work

1955 • 0 citations